Trial
NCT00423189
Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
David M. Brown, M.D.
Collaborators
Novartis Pharmaceuticals
Condition
Age-Related Macular Degeneration
Intervention
Ranibizumab (Lucentis)
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-04